This is a two-arm randomized controlled trial to compare telephone-based depression self-management (UPLIFT) to telephone-based support groups (BOOST). A sample of 120 English- and Spanish-speaking people with epilepsy (PWE) with elevated depressive symptoms will be enrolled. Both interventions are 8-week programs delivered in one-hour weekly sessions to groups of about 6 participants. Changes in depressive symptoms, quality of life and seizures will be assessed over 12 months. The trial will also examine mediators and moderators of treatment effects.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Presence of clinically significant depressive symptoms
Timeframe: Baseline Visit
Presence of clinically significant depressive symptoms
Timeframe: 3 month visit
Presence of clinically significant depressive symptoms
Timeframe: 6 month visit
Presence of clinically significant depressive symptoms
Timeframe: 12 month visit